Company Filing History:
Years Active: 2020-2022
Title: Finith E Jernigan, III: Innovator in Pharmaceutical Modulation
Introduction
Finith E Jernigan, III is a notable inventor based in Wilmington, DE (US). He has made significant contributions to the field of pharmaceuticals, particularly in the modulation of the stimulator of interferon genes (STING) protein. With a total of 2 patents, his work has the potential to impact therapeutic approaches in various medical conditions.
Latest Patents
Jernigan's latest patents include innovative compounds known as oxoacridinyl acetic acid derivatives. These compounds, or their pharmaceutically acceptable salts or esters, are capable of binding to and modulating the activity of the STING protein. The methods involving these compounds as effective modulators of STING are also outlined in his patents, showcasing their potential utility in medical applications.
Career Highlights
Throughout his career, Jernigan has worked with several companies, including Stingthera, Inc. and Silicon Swat, Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in pharmaceutical research.
Collaborations
Some of Jernigan's notable coworkers include Brian T Chamberlain and James M Rice. Their collaborative efforts have likely played a role in the development of his patented technologies.
Conclusion
Finith E Jernigan, III is a distinguished inventor whose work in pharmaceutical modulation has the potential to influence future medical therapies. His contributions to the field are marked by his innovative patents and collaborative spirit.